Table 5.
Cardiovascular risk | β | LL | UL | P value |
---|---|---|---|---|
10‐year ASCVD risk* | ||||
Age 40–49 y, n=64 240 | 1.46 | 1.30 | 1.62 | <0.0001 |
Age 50–59 y, n=86 425 | 1.70 | 1.46 | 1.93 | <0.0001 |
Age 60–69 y, n=74 355 | 0.76 | 0.31 | 1.20 | 0.0008 |
Age 70–75 y, n=22 889 | −0.04 | −1.26 | 1.18 | 0.95 |
OR | LL | UL | P value | |
---|---|---|---|---|
30‐year lifetime risk* | ||||
Age 18–29 y, n=24 960 | 2.98 | 2.64 | 3.37 | <0.0001 |
Age 30–39 y, n=46 559 | 3.20 | 2.92 | 3.52 | <0.0001 |
Age 40–49 y, n=65 281 | 2.89 | 2.62 | 3.13 | <0.0001 |
Age 50–59 y, n=86 508 | 0.45 | 0.41 | 0.48 | <0.0001 |
β indicates unstandardized regression coefficient; LL, 95% lower confidence limit; OR, odds ratio; SMI, serious mental illness; and UL; 95% upper confidence limit.
10‐year ASCVD risk and 30‐year lifetime risk are calculated only for patients without CVD.